Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Chatterji
Arun K. Chatterji, Neenah, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20090053332 | Compositions for diabetes treatment and prophylaxis - Gurmarin containing compositions are useful for modulation of glucose metabolism and the treatment of diabetes. Glucose metabolism in a human patient is regulated by isolated gurmarin-containing dosage forms that optionally contain a non-metabolizable polysaccharide such as the exudate of | 02-26-2009 |
| 20100297267 | Compositions for diabetes treatment and prophylaxis - Gurmarin containing compositions are useful for modulation of glucose metabolism and the treatment of diabetes. Glucose metabolism in a human patient is regulated by isolated gurmarin-containing dosage forms that optionally contain a non-metabolizable polysaccharide such as the exudate of | 11-25-2010 |
Ashish Chatterji, East Brunswick, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20080293787 | PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE DRUGS - The invention relates to solid dispersions of poorly soluble compounds formed by co-precipitation and hot melt extrusion, resulting in improved stability and bioavailability. The invention also relates to hot melt extrusion processes used to prepare such solid dispersions. | 11-27-2008 |
| 20100184716 | PHARMACEUTICAL COMPOSITIONS WITH SUPERIOR PRODUCT PERFORMANCE AND PATIENT COMPLIANCE - The present invention provides novel formulations of isobutyric acid (2R,3R,4R,5R)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-4-fluoro-2-isobutyryloxymethyl-4-methyl-tetrahydro-furan-3-yl ester) and hydroxypropylcellulose that provide high bulk density, low particle size better suited for improved compression and flow, good compression, and fast dissolution profiles. | 07-22-2010 |
| 20120039999 | PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE 5 RECEPTOR (MGLU5) ANTAGONISTS - Pharmaceutical compositions of metabotropic glutamate 5 receptor (mGlu5) antagonists or a pharmacologically acceptable salt thereof are disclosed. The compositions contain the therapeutic active compound with non-ionic polymer and ionic polymer, binder and fillers in either matrix pellet, matrix tablet or coated pellets. The compositions provide a pH-independent in vitro release profile with NMT 70% in one hour, NMT 85% in 4 hour, and NLT 80% in 8 hours. The compositions are useful for the treatment of CNS disorders, such as Treatment-Resistant Depression (TRD) and Fragile X Syndrome. | 02-16-2012 |
| 20120040008 | PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE 5 RECEPTOR (MGLU5) ANTAGONISTS - Pharmaceutical compositions of metabotropic glutamate 5 receptor (mGlu5) antagonists or a pharmacologically acceptable salt thereof are disclosed. The compositions contain the therapeutic active compound with non-ionic polymer and ionic polymer, binder and fillers in either matrix pellet, matrix tablet or coated pellets. The compositions provide a pH-independent in vitro release profile with NMT 70% in one hour, NMT 85% in 4 hour, and NLT 80% in 8 hours. The compositions are useful for the treatment of CNS disorders, such as Treatment-Resistant Depression (TRD) and Fragile X Syndrome. | 02-16-2012 |
Ashish Chatterji, New Brunswick, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110028524 | PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE DRUGS - The invention relates to solid dispersions of poorly soluble compounds formed by co-precipitation and hot melt extrusion, resulting in improved stability and bioavailability. The invention also relates to hot melt extrusion processes used to prepare such solid dispersions. | 02-03-2011 |
| 20110245305 | PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE DRUGS - The invention relates to solid dispersions of poorly soluble compounds formed by co-precipitation and hot melt extrusion, resulting in improved stability and bioavailability. The invention also relates to hot melt extrusion processes used to prepare such solid dispersions. | 10-06-2011 |
Bijon Chatterji, Hannover DE
| Patent application number | Description | Published |
|---|---|---|
| 20110082089 | BIOMARKERS FOR MONITORING OR PREDICTING THE TREATMENT OF CANCER - We provide for the diagnosis, prognosis and/or treatment monitoring of lung cancer or bronchial dysplasia, and the use thereof for predicting and monitoring therapeutic intervention in dysplasia or cancer patients. According to the invention at least one biomarker selected from the group consisting of APOE, APOC3, A1AT6, A2MG, PROP, TTHY, A1AG8, APOA1, APOH, GPX3, MUP8, RETBP, SAMP, VTDB, S6A11, EGFR, ApoA4, ApoM, a-raf, fetuin B, GSN, PLG, VPS28, and particular peptide sequences derived thereof, is used in the diagnosis, prognosis and/or treatment monitoring of cancer or dysplasia, in particular of lung cancer or the level of at least one of said biomarkers is measured in a body fluid sample, in particular in a blood serum sample, of a patient suffering from or being susceptible to cancer or dysplasia. | 04-07-2011 |
Monalisa Chatterji, Karnataka IN
| Patent application number | Description | Published |
|---|---|---|
| 20110002939 | MONOCLONAL ANTIBODY AND A METHOD THEREOF - The present invention relates to a humanized IgG1 isotype anti-CD6 antibody (T1h) that binds to the Scavenger receptor cysteine-rich (SRCR) domain 1(D1) of CD6 present on the surface of thymic epithelial cells, monocytes, activated T cells and a variety of other cells types. | 01-06-2011 |
Siddhartha Chatterji, New Delhi, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20120046979 | USING COMMERCIAL SHARE OF WALLET TO RATE BUSINESS PROSPECTS - Commercial size of spending wallet (“CSoSW”) is the total business spend of a business including cash but excluding bartered items. Commercial share of wallet (“CSoW”) is the portion of the spending wallet that is captured by a particular financial company. A modeling approach utilizes various data sources to provide outputs that describe a company's spend capacity. Research analysts can use CSoW/CSoSW to provide a comprehensive and robust indication of the business prospects of a rated company. | 02-23-2012 |
Sourav Chatterji, Fremont, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120095862 | COMPUTER SYSTEM AND METHOD FOR ANALYZING DATA SETS AND GENERATING PERSONALIZED RECOMMENDATIONS - Embodiments of the invention relate to a computer-implemented method and system for generating personalized recommendations for a target user based at least on stored data about the target user. The method comprises obtaining, at the server computer, data from a plurality of data sources, including entity data associated with a plurality of entities, stored in an entity database, or personal data associated with a plurality of users, stored in a user database. The personalized recommendations system then merges the entity data or personal data and maps the entity or personal data to a corresponding entity or target user, respectively. The entity or personal data is differentiated, a relevance is determined, a weight is assigned to the data and corresponding source to canonicalize the data, the respective databases are updated with the corresponding data, and then a set of personalized recommendations to the target user is generated using the updated databases. | 04-19-2012 |
Varun Chatterji, Singapore SG
| Patent application number | Description | Published |
|---|---|---|
| 20110225635 | NON-OBTRUSIVE SECURITY SYSTEM FOR DEVICES - A security system is provided including providing a device including: storing a security rule for operation of the device when an event occurs; and implementing the security rule upon the occurrence of the event to allow non-obtrusive user access to the device. | 09-15-2011 |
Vishwajeet Chatterji, Redondo Beach, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110028093 | Bluetooth Proximity Detection System and Method of Interacting With One or More Bluetooth Devices - Some embodiments teach an apparatus for determining a proximity of one or more first Bluetooth devices. The apparatus can include: (a) at least one Bluetooth base station with (1) a Bluetooth transmitter configured to transmit one or more service discovery requests to the one or more first Bluetooth devices; and (2) a Bluetooth receiver configured to receive one or more responses from the one or more first Bluetooth devices to the one or more service discovery requests; and (b) a computational module configured to run on one or more processors and further configured to determine one or more approximate distances between the at least one Bluetooth base station and the one or more first Bluetooth devices based on the one or more responses from the one or more first Bluetooth devices. Other embodiments are disclosed. | 02-03-2011 |